AMERICAN CENTURY COMPANIES INC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 748054 KANSAS CITY, MO

Position in FULC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,198,376

-$584,894 QoQ

Shares Held

156,242

-0.9% QoQ

Ownership

0.234%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#45

of 168 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AMERICAN CENTURY COMPANIES INC holds $3,844,311,104 across 169 Biotechnology names. FULC ranks #84 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,802,363	$596,347,845
2	REGN	Regeneron Pharmaceuticals, Inc.	562,097	$434,298,626
3	VRTX	Vertex Pharmaceuticals Inc / Ma	813,285	$363,164,283
4	ASND	Ascendis Pharma A/S	1,397,119	$319,563,028
5	INSM	INSMED Inc	925,799	$151,386,652
6	ARGX	Argenx SE	173,700	$126,844,425
7	IONS	Ionis Pharmaceuticals Inc	1,663,803	$124,934,967
8	CPRX	Catalyst Pharmaceuticals, Inc.	4,138,416	$102,467,180

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,198,376	156,242	-0.9%	Shares	Defined	2026-05-15
2025-12-31	$1,783,270	157,672	+3.6%	Shares	Defined	2026-02-13
2025-09-30	$1,400,644	152,244	+15.0%	Shares	Defined	2025-11-12
2025-06-30	$910,561	132,349	+7.0%	Shares	Defined	2025-08-12
2025-03-31	$356,287	123,711	+2.6%	Shares	Defined	2025-05-13
2024-12-31	$566,871	120,611	+5.9%	Shares	Defined	2025-02-11
2024-09-30	$406,412	113,841	+9.1%	Shares	Defined	2024-11-12
2024-06-30	$647,100	104,371	+13.2%	Shares	Defined	2024-08-07
2024-03-31	$870,405	92,204	+42.7%	Shares	Defined	2024-05-14
2023-12-31	$436,205	64,623	+127.4%	Shares	Defined	2024-02-13
2023-06-30	$93,776	28,417	+40.7%	Shares	Defined	2023-08-14
2023-03-31	$57,578	20,203	—	Shares	Defined	2023-05-11
No filing history on record for this holder in this stock.